Donald O'Boyle 2nd

Donald O'Boyle 2nd possesses over 30 years of extensive experience in biomedical research, with a focus on innovative treatments for viral infections, particularly HIV and Hepatitis B. Currently serving as a Scientific Leader at ViiV Healthcare since November 2019, Donald O'Boyle 2nd is dedicated to the development of novel therapies aimed at curing HIV. Previous roles include Research Scientist at Arvinas, where Donald O'Boyle 2nd advanced protein degradation technologies for challenging targets, and Senior Research Investigator at Bristol-Myers Squibb, leading initiatives in immuno-oncology and viral disease research. Donald O'Boyle 2nd began research career at The Wistar Institute as a Research Technician. Educational background includes a B.S. in Biochemistry from the University of Pennsylvania and an A.S. in Chemistry and Physics from Montgomery County Community College.